ARCT logo

ARCT

Profile

Full Name

Arcturus Therapeutics Holdings Inc.

Ticker Symbol

ARCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 22, 2013

Indexes

Not included

Website

http://arcturusrx.com

Employees

174

Key Details

Price

$10.57(+3.83%)

Market cap

$286.66M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$138.39M(-12.27% YoY)

Annual EPS

-$3.00(-167.86% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.57
ARCT price is $10.57

30-Day Relative Volume

1.36
ARCT 30-day relative volume is 1.36

Price Performance

Price Most recent change

+3.83%
ARCT price was up +3.83% on Apr 15, 2025

Price YTD change

-37.71%
ARCT price is down -37.71% since January 1st

Price 1-year change

-64.92%
ARCT price is down -64.92% year-on-year

Price 3-year change

-60.13%
ARCT price is down -60.13% over the past 3 years

Price Range

Price All-time high

$188.72
ARCT price is currently -94.40% below its historical high of $188.72

Price 3-year low

$8.04
ARCT price is currently +31.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$286.66M
ARCT market capitalization is $286.66 million

Market cap 3-year change

-59.07%
ARCT market capitalization is down -59.07% over the past 3 years

Market cap All-time high

$3.06B
ARCT market capitalization is currently -90.64% below its historical high of $3.06 billion

Market cap sector rank

62.5%
ARCT market capitalization is higher than 62.5% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.75%
ARCT shares outstanding is up +0.75% year-on-year

Shares Outstanding 3-Year Change

+2.7%
ARCT shares outstanding is up +2.7% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.24
ARCT beta is 1.24

200-day SMA

$18.28
ARCT price is currently -42.19% below its 200-day simple moving average

50-day SMA

$13.89
ARCT price is currently -23.89% below its 50-day simple moving average

RSI

42.78
ARCT 14-day relative strength index is 42.78

Volume

1.36
ARCT 30-day relative volume is 1.36

ATR

$0.94
ARCT average true range is $0.94

10-day Historical Volatility

91.46%
ARCT 10-day historical volatility is 91.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$138.39M
ARCT annual revenue is $138.39 million

Revenue Analysts estimate

$101.88M
ARCT annual revenue is currently +35.84% higher than the consensus analysts' forecast

Revenue 1-year change

-12.27%
ARCT annual revenue is down -12.27% year-on-year

Revenue Sector rank

60%
ARCT annual revenue is higher than 60% of companies in Healthcare sector

EPS

EPS

-$3.00
ARCT annual earnings per share is -$3.00

EPS Analysts estimate

-$4.80
ARCT annual earnings per share is currently -37.53% lower than the consensus analysts' forecast

EPS 1-year change

-167.86%
ARCT annual earnings per share is down -167.86% year-on-year

EPS Sector rank

29.66%
ARCT annual earnings per share is higher than 29.66% of companies in Healthcare sector

Profit

Gross profit

-
ARCT annual gross profit value is unknown

Gross margin

-
ARCT annual gross profit margin value is unknown

Operating profit

-$95.67M
ARCT annual operating income is -$95.67 million

Operating margin

-69.13%
ARCT annual operating profit margin is -69.13%

Net income

-$80.94M
ARCT annual net profit is -$80.94 million

Net margin

-58.49%
ARCT annual net profit margin is -58.49%

Expenses

Total expenses

$234.06M
ARCT annual total expenses is $234.06 million

Operating expenses

$234.06M
ARCT annual total operating expenses is $234.06 million

Cost of goods sold

-
ARCT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$52.82M
ARCT annual SGA is $52.82 million

Depreciation and amortization

$3.54M
ARCT annual depreciation & amortization is $3.54 million

Interest expense

$0.00
ARCT annual interest expense is $0.00

Income tax

-$4000.00
ARCT annual income tax is -$4000.00

EBIT & EBITDA

EBIT

-$80.94M
ARCT annual earnings before interest & taxes is -$80.94 million

EBITDA

-$77.40M
ARCT annual EBITDA is -$77.40 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$344.07M
ARCT annual total assets is $344.07 million

Non current assets

$38.09M
ARCT annual long term assets is $38.09 million

Current assets

$305.98M
ARCT annual total current assets is $305.98 million

Cash and cash equivalents

$237.03M
ARCT annual cash & cash equivalents is $237.03 million

Accounts receivable

$3.97M
ARCT annual accounts receivable is $3.97 million

Inventory

-
ARCT annual inventory value is unknown

Liabilities

Total liabilities

$103.09M
ARCT annual total liabilities is $103.09 million

Long term liabilities

$37.60M
ARCT annual total long term liabilities is $37.60 million

Current liabilities

$65.49M
ARCT annual total current liabilities is $65.49 million

Accounts payable

$7.19M
ARCT annual accounts payable is $7.19 million

Debt

Total debt

$28.55M
ARCT annual total debt is $28.55 million

Total debt 1-year change

-5.51%
ARCT annual total debt is down -5.51% year-on-year

Long term debt

$25.00M
ARCT annual long term debt is $25.00 million

Short term debt

$3.55M
ARCT annual short term debt is $3.55 million

Equity & Capital

Shareholders equity

$240.98M
ARCT annual stockholders equity is $240.98 million

Book value

$240.98M
ARCT annual book value is $240.98 million

Retained earnings

-$448.81M
ARCT annual retained earnings is -$448.81 million

Working capital

$240.49M
ARCT annual working capital is $240.49 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$59.75M
ARCT annual cash flow from operations is -$59.75 million

Cash from operations 1-year change

-230.11%
ARCT annual cash flow from operations is down -230.11% year-on-year

Cash from investing

-$648.00K
ARCT annual cash flow from investing activities is -$648.00 thousand

Cash from investing 1-year change

+77.66%
ARCT annual cash flow from investing activities is up +77.66% year-on-year

Cash from financing

$5.42M
ARCT annual cash flow from financing activities is $5.42 million

Cash from financing 1-year change

+122.49%
ARCT annual cash flow from financing activities is up +122.49% year-on-year

CAPEX

CAPEX

$648.00K
ARCT annual capital expenditures is $648.00 thousand

CAPEX 1-year change

-77.66%
ARCT annual capital expenditures is down -77.66% year-on-year

Free Cash Flow

Free cash flow

-$60.40M
ARCT annual free cash flow is -$60.40 million

Free cash flow 1-year change

-187.6%
ARCT annual free cash flow is down -187.6% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ARCT annual gross profit margin value is unknown

Operating margin

-69.13%
ARCT annual operating profit margin is -69.13%

Net margin

-58.49%
ARCT annual net profit margin is -58.49%

ROA & ROE

ROA

-20.93%
ARCT annual return on assets is -20.93%

ROE

-31.16%
ARCT annual return on equity is -31.16%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ARCT price to earnings ratio value is unknown

PE ratio Sector rank

-
ARCT price to earnings ratio is unknown

PB Ratio

PB ratio

1.19
ARCT price to book ratio is 1.19

PB ratio Sector rank

48.4%
ARCT price to book ratio is higher than 48.4% of companies in Healthcare sector

PS Ratio

PS ratio

2.07
ARCT price to sales ratio is 2.07

PS ratio Sector rank

43.46%
ARCT price to sales ratio is higher than 43.46% of companies in Healthcare sector

Enterprise value

Enterprise value

$78.18M
ARCT enterprise value is $78.18 million

Enterprise value Sector rank

46.4%
ARCT enterprise value is higher than 46.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.12
ARCT EV/EBITDA is -1.12

EV/EBITDA Sector rank

41.25%
ARCT EV/EBITDA is higher than 41.25% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.67
ARCT annual current ratio is 4.67

Quick ratio

-
ARCT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ARCT annual debt to equity ratio is 0.00

Interest coverage ratio

-
ARCT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ARCT piotroski f-score value is unknown

Altman Z-Score

0.31
ARCT altman z-score is 0.31

Analyst ratings

Recent major analysts updates

Apr 10, 25 HC Wainwright & Co.
Buy
Mar 10, 25 Canaccord Genuity
Buy
Mar 7, 25 Wells Fargo
Overweight
Mar 7, 25 HC Wainwright & Co.
Buy
Mar 7, 25 Cantor Fitzgerald
Overweight
Feb 18, 25 HC Wainwright & Co.
Buy
Feb 14, 25 HC Wainwright & Co.
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 7, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

OLMA logo
Olema Pharmaceuticals (OLMA)
PSNL logo
Personalis (PSNL)
DH logo
Definitive Healthcare (DH)
MXCT logo
MaxCyte (MXCT)
HRTX logo
Heron Therapeutics (HRTX)
Anbio Biotechnology Class A (NNNN)
CMPS logo
COMPASS Pathways (CMPS)
AURA logo
Aura Biosciences (AURA)
Septerna (SEPN)
  • What is the ticker symbol for Arcturus Therapeutics Holdings?
  • Does Arcturus Therapeutics Holdings pay dividends?
  • What sector is Arcturus Therapeutics Holdings in?
  • What industry is Arcturus Therapeutics Holdings in?
  • What country is Arcturus Therapeutics Holdings based in?
  • When did Arcturus Therapeutics Holdings go public?
  • Is Arcturus Therapeutics Holdings in the S&P 500?
  • Is Arcturus Therapeutics Holdings in the NASDAQ 100?
  • Is Arcturus Therapeutics Holdings in the Dow Jones?
  • When was Arcturus Therapeutics Holdings's last earnings report?
  • When does Arcturus Therapeutics Holdings report earnings?
  • Should I buy Arcturus Therapeutics Holdings stock now?

What is the ticker symbol for Arcturus Therapeutics Holdings?

The ticker symbol for Arcturus Therapeutics Holdings is NASDAQ:ARCT

Does Arcturus Therapeutics Holdings pay dividends?

No, Arcturus Therapeutics Holdings does not pay dividends

What sector is Arcturus Therapeutics Holdings in?

Arcturus Therapeutics Holdings is in the Healthcare sector

What industry is Arcturus Therapeutics Holdings in?

Arcturus Therapeutics Holdings is in the Biotechnology industry

What country is Arcturus Therapeutics Holdings based in?

Arcturus Therapeutics Holdings is headquartered in United States

When did Arcturus Therapeutics Holdings go public?

Arcturus Therapeutics Holdings's initial public offering (IPO) was on May 22, 2013

Is Arcturus Therapeutics Holdings in the S&P 500?

No, Arcturus Therapeutics Holdings is not included in the S&P 500 index

Is Arcturus Therapeutics Holdings in the NASDAQ 100?

No, Arcturus Therapeutics Holdings is not included in the NASDAQ 100 index

Is Arcturus Therapeutics Holdings in the Dow Jones?

No, Arcturus Therapeutics Holdings is not included in the Dow Jones index

When was Arcturus Therapeutics Holdings's last earnings report?

Arcturus Therapeutics Holdings's most recent earnings report was on Mar 6, 2025

When does Arcturus Therapeutics Holdings report earnings?

The next expected earnings date for Arcturus Therapeutics Holdings is May 8, 2025

Should I buy Arcturus Therapeutics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page